The PSA nadir that indicates potential cure after radiotherapy for prostate cancer
- 31 May 1997
- Vol. 49 (3) , 322-326
- https://doi.org/10.1016/s0090-4295(96)00666-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate Cancer: The relationship between nadir level and disease-free survivalJournal of Urology, 1996
- The Periurethral Glands do not Significantly Influence the Serum Prostate Specific Antigen ConcentrationJournal of Urology, 1996
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- Prostate Specific Antigen Following Radiotherapy for Local Prostate CancerJournal of Urology, 1995
- Radiation therapy for T1 and T2 prostate cancer: Prostate-specific antigen and disease outcomeUrology, 1995
- The Clinical Usefulness of Prostate Specific Antigen: Update 1994Journal of Urology, 1994
- PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- The Value of Serial Prostate Specific Antigen Determinations 5 Years after Radiotherapy: Steeply Increasing Values Characterize 80% of PatientsJournal of Urology, 1993
- The Enhanced Detection of Persistent Disease After Prostatectomy with a New Prostate Specific Antigen ImmunoassayJournal of Urology, 1993
- Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostateUrology, 1993